Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × TAS-119 × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

Cisplatin 70 Paclitaxel 68 pembrolizumab 65 Carboplatin 61 Irinotecan 59 Injections 53 Gemcitabine 53 Docetaxel 49 Fluorouracil 35 Cyclophosphamide 35 Pemetrexed 34 Oxaliplatin 31 Capecitabine 30 Bevacizumab 29 Leucovorin 27 atezolizumab 23 Nivolumab 23 tislelizumab 19 Etoposide 18 Cetuximab 17 durvalumab 16 Temozolomide 16 Bortezomib 16 alvocidib 15 Topotecan 15 olaparib 14 Sorafenib 14 Erlotinib Hydrochloride 14 fludarabine 13 Rifampin 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02448589 2024-09-04

An Investigation of TAS-119 Monotherapy

Taiho Oncology, Inc.

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡